Neurological Research,
Год журнала:
2022,
Номер
44(7), С. 571 - 582
Опубликована: Янв. 6, 2022
Coronavirus
disease
(COVID-19)
arising
from
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
viral
infection
has
caused
a
worldwide
pandemic,
mainly
owing
to
its
highly
virulent
nature
stemming
very
strong
and
efficacious
binding
the
angiotensin
converting
enzyme-2
(ACE2)
receptor.
As
pandemic
developed,
increasing
numbers
of
COVID-19
patients
with
neurological
manifestations
were
reported,
strongly
suggesting
causal
relationship.
Indeed,
direct
invasion
SARS-CoV-2
particles
into
brain
can
occur
through
cribriform
plate
via
olfactory
nerves,
passage
damaged
blood-brain-barrier,
or
haematogenic
infiltration
infected
leukocytes.
Neurological
complications
range
potentially
fatal
encephalopathy
stroke,
onset
headaches
dizziness,
which
despite
their
apparent
innocuous
presentation
may
still
imply
more
sinister
pathology.
Here,
we
summarize
most
recent
knowledge
on
presentations
typically
being
associated
COVID-19,
whilst
providing
potential
pathophysiological
mechanisms.
The
latter
are
centered
upon
hypoxic
injury,
generation
cytokine
storm
attendant
immune-mediated
damage,
prothrombotic
state.
A
better
understanding
both
neuroinvasive
properties
will
be
important
improve
patient
outcomes.
COVID-19,
with
persistent
and
new
onset
of
symptoms
such
as
fatigue,
post-exertional
malaise,
cognitive
dysfunction
that
last
for
months
impact
everyday
functioning,
is
referred
to
Long
COVID
under
the
general
category
post-acute
sequelae
SARS-CoV-2
infection
(PASC).
PASC
highly
heterogenous
may
be
associated
multisystem
tissue
damage/dysfunction
including
acute
encephalitis,
cardiopulmonary
syndromes,
fibrosis,
hepatobiliary
damages,
gastrointestinal
dysregulation,
myocardial
infarction,
neuromuscular
neuropsychiatric
disorders,
pulmonary
damage,
renal
failure,
stroke,
vascular
endothelial
dysregulation.
A
better
understanding
pathophysiologic
mechanisms
underlying
essential
guide
prevention
treatment.
This
review
addresses
potential
hypotheses
connect
long-term
health
consequences.
Comparisons
between
other
virus-initiated
chronic
syndromes
myalgic
encephalomyelitis/chronic
fatigue
syndrome
postural
orthostatic
tachycardia
will
addressed.
Aligning
identifying
potentially
regulated
common
underlining
pathways
necessary
true
nature
PASC.
The
discussed
contributors
include
from
injury
one
or
more
organs,
reservoirs
replicating
virus
its
remnants
in
several
tissues,
re-activation
latent
pathogens
Epstein-Barr
herpes
viruses
COVID-19
immune-dysregulated
environment,
interactions
host
microbiome/virome
communities,
clotting/coagulation
dysfunctional
brainstem/vagus
nerve
signaling,
dysautonomia
autonomic
dysfunction,
ongoing
activity
primed
immune
cells,
autoimmunity
due
molecular
mimicry
pathogen
proteins.
individualized
suggests
different
therapeutic
approaches
required
best
manage
specific
patients.
Abstract
COVID-19,
which
is
caused
by
the
SARS-CoV-2,
has
ravaged
world
for
past
2
years.
Here,
we
review
current
state
of
research
into
disease
with
focus
on
its
history,
human
genetics
and
genomics
transition
from
pandemic
to
endemic
phase.
We
are
particularly
concerned
lack
solid
information
initial
phases
that
highlighted
necessity
better
preparation
face
similar
future
threats.
On
other
hand,
gratified
progress
genetic
susceptibility
investigations
believe
now
time
explore
The
latter
will
require
worldwide
vigilance
cooperation,
especially
in
emerging
countries.
In
phase,
vaccination
rates
have
lagged
developed
countries
should
assist,
as
warranted,
bolstering
worldwide.
also
discuss
status
vaccines
outlook
COVID-19.
Most
COVID-19
patients
recovered
with
low
mortality;
however,
some
experienced
long-term
symptoms
described
as
"long-COVID"
or
"Post-COVID
syndrome"
(PCS).
Patients
may
have
persisting
for
weeks
after
acute
SARS-CoV-2
infection,
including
dyspnea,
fatigue,
myalgia,
insomnia,
cognitive
and
olfactory
disorders.
These
last
months
in
patients.
PCS
progress
association
the
development
of
mast
cell
activation
syndrome
(MCAS),
which
is
a
distinct
kind
disorder,
characterized
by
hyper-activation
cells
inappropriate
excessive
release
chemical
mediators.
survivors,
mainly
women,
persistent
severe
fatigue
10
recovery
history
neuropsychiatric
disorders
are
more
prone
to
develop
PCS.
High
D-dimer
levels
blood
urea
nitrogen
were
observed
be
risk
factors
associated
pulmonary
dysfunction
survivors
3
post-hospital
discharge
has
systemic
manifestations
that
resolve
time
no
further
complications.
However,
final
outcomes
chiefly
unknown.
Persistence
inflammatory
reactions,
autoimmune
mimicry,
reactivation
pathogens
together
host
microbiome
alterations
contribute
The
deregulated
mediators
MCAS
produces
extraordinary
during
course
infection
correlated
severity
Therefore,
treated
antihistamines,
inhibition
synthesis
mediators,
mediator
release,
degranulation
cells.
Biomedicines,
Год журнала:
2023,
Номер
11(8), С. 2287 - 2287
Опубликована: Авг. 17, 2023
The
COVID-19
pandemic
caused
much
illness,
many
deaths,
and
profound
disruption
to
society.
production
of
‘safe
effective’
vaccines
was
a
key
public
health
target.
Sadly,
unprecedented
high
rates
adverse
events
have
overshadowed
the
benefits.
This
two-part
narrative
review
presents
evidence
for
widespread
harms
novel
product
mRNA
adenovectorDNA
is
in
attempting
provide
thorough
overview
arising
from
new
technology
that
relied
on
human
cells
producing
foreign
antigen
has
pathogenicity.
first
paper
explores
peer-reviewed
data
counter
attached
these
technologies.
Spike
protein
pathogenicity,
termed
‘spikeopathy’,
whether
SARS-CoV-2
virus
or
produced
by
vaccine
gene
codes,
akin
‘synthetic
virus’,
increasingly
understood
terms
molecular
biology
pathophysiology.
Pharmacokinetic
transfection
through
body
tissues
distant
injection
site
lipid-nanoparticles
viral-vector
carriers
means
‘spikeopathy’
can
affect
organs.
inflammatory
properties
nanoparticles
used
ferry
mRNA;
N1-methylpseudouridine
employed
prolong
synthetic
function;
biodistribution
DNA
codes
translated
spike
proteins,
autoimmunity
via
contribute
harmful
effects.
reviews
autoimmune,
cardiovascular,
neurological,
potential
oncological
effects,
autopsy
spikeopathy.
With
gene-based
therapeutic
technologies
planned,
re-evaluation
necessary
timely.
POTS
(Postural
Orthostatic
Tachycardia
Syndrome)
is
a
multisystem
disorder
characterized
by
the
abnormal
autonomic
response
to
an
upright
posture,
causing
orthostatic
intolerance
and
excessive
tachycardia
without
hypotension.
Recent
reports
suggest
that
significant
percentage
of
COVID-19
survivors
develop
within
6
8
months
infection.
Prominent
symptoms
include
fatigue,
intolerance,
tachycardia,
cognitive
impairment.
The
exact
mechanisms
post-COVID-19
are
unclear.
Still,
different
hypotheses
have
been
given,
including
autoantibody
production
against
nerve
fibers,
direct
toxic
effects
SARS-CoV-2,
or
sympathetic
nervous
system
stimulation
secondary
Physicians
should
high
suspicion
in
survival
when
presented
with
dysfunction
conduct
diagnostic
tests
like
Tilt
table
others
confirm
it.
management
COVID-19-related
requires
comprehensive
approach.
Most
patients
respond
initial
non-pharmacological
options,
but
become
more
severe
they
do
not
approach,
pharmacological
options
considered.
We
limited
understanding
knowledge
POTS,
further
research
warranted
improve
our
formulate
better
plan.
Frontiers in Neurology,
Год журнала:
2022,
Номер
13
Опубликована: Май 27, 2022
Introduction
On
March
11,
2020,
the
World
Health
Organization
sounded
COVID-19
pandemic
alarm.
While
efforts
in
first
few
months
focused
on
reducing
mortality
of
infected
patients,
there
is
increasing
data
effects
long-term
infection
(Post-COVID-19
condition).
Among
different
symptoms
described
after
acute
infection,
those
derived
from
autonomic
dysfunction
are
especially
frequent
and
limiting.
Objective
To
conduct
a
narrative
review
synthesizing
current
evidence
signs
dysautonomia
patients
diagnosed
with
COVID-19,
together
compilation
available
treatment
guidelines.
Results
Autonomic
associated
SARS-CoV-2
occurs
at
temporal
stages.
Some
proposed
pathophysiological
mechanisms
include
direct
tissue
damage,
immune
dysregulation,
hormonal
disturbances,
elevated
cytokine
levels,
persistent
low-grade
infection.
Acute
has
impact
risk,
given
its
repercussions
respiratory,
cardiovascular,
neurological
systems.
Iatrogenic
side
effect
caused
by
drugs
used
and/or
admission
to
intensive
care
unit.
Finally,
late
2.5%
Post-COVID-19
condition.
orthostatic
hypotension
neurally-mediated
syncope
should
be
considered,
postural
tachycardia
syndrome
(POTS)
appears
most
common
phenotype
among
these
patients.
A
diagnostic
guidelines
each
type
dysautonomic
condition
was
done.
Conclusion
Symptoms
deriving
involvement
affected
COVID-19.
These
have
great
quality
life
both
short
medium
long
term.
better
understanding
Post-COVID
manifestations
that
affect
nervous
system,
targeted
therapeutic
management
could
help
reduce
sequelae
if
we
act
earliest
phases
disease.
Anaesthesia,
Год журнала:
2022,
Номер
77(9), С. 1039 - 1050
Опубликована: Июль 18, 2022
Summary
The
COVID‐19
pandemic
transformed
everyday
life,
but
the
implications
were
most
impactful
for
vulnerable
populations,
including
patients
with
chronic
pain.
Moreover,
persistent
pain
is
increasingly
recognised
as
a
key
manifestation
of
long
COVID.
This
narrative
review
explores
consequences
Publications
identified
related
to
influence
on
burden
pain,
development
new‐onset
because
COVID
proposed
mechanisms
and
vaccines
interventions.
Broadly,
underlying
due
SARS‐CoV‐2
infection
could
be
caused
by
‘systemic
inflammatory‐immune
mechanisms’,
‘direct
neuropathic
mechanisms’
or
‘secondary
viral
treatment’.
Existing
populations
variably
impacted
social
determinants
health
appeared
degree
effect.
increased
absolute
numbers
headache.
In
acute
phase,
headache
presenting
symptom
predicted
milder
course.
New‐onset
was
reportedly
common
likely
involves
multiple
mechanisms;
however,
its
prevalence
decreases
over
time
symptoms
appear
fluctuate.
Patients
requiring
intensive
support
particularly
susceptible
symptoms.
Some
evidence
suggests
steroid
exposure
(often
used
interventions)
may
affect
vaccine
efficacy,
there
no
clinical
repercussions
date.
Although
existing
management
help
symptomatic
relief,
need
advance
research
focusing
mechanism‐based
treatments
within
domain
multidisciplinary
care.